Solid Phase Pegylation of Hemoglobin
A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange chromatography column and adsorbed by the solid medium. Succinimidyl carbonate mPEG was introduced in the mobile phase after the adsorption....
Saved in:
Published in | Artificial cells, blood substitutes, and immobilization biotechnology Vol. 37; no. 4; pp. 147 - 155 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa UK Ltd
01.01.2009
Taylor & Francis |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange chromatography column and adsorbed by the solid medium. Succinimidyl carbonate mPEG was introduced in the mobile phase after the adsorption. Pegylation took place between the hemoglobin on the solid phase, and the pegylation reagent in the liquid phase. A further elution was carried out to separate the pegylated and the unpegylated protein. Analysis by HPSEC, SDS-PAGE, and MALLS demonstrated that the fractions eluted from the solid phase contained well-defined components. Pegylated hemoglobin with one PEG chain was obtained with the yield of 75%, in comparison to the yield of 30% in the liquid phase pegylation. The P50 values of the mono-pegylated hemoglobin, prepared with SC-mPEG 5kDa, 10kDa and 20kDa, were 19.97, 20.23 and 20.54 mmHg, which were much closer to the value of red blood cells than that of pegylated hemoglobin prepared with the conventional method. |
---|---|
AbstractList | A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange chromatography column and adsorbed by the solid medium. Succinimidyl carbonate mPEG was introduced in the mobile phase after the adsorption. Pegylation took place between the hemoglobin on the solid phase, and the pegylation reagent in the liquid phase. A further elution was carried out to separate the pegylated and the unpegylated protein. Analysis by HPSEC, SDS-PAGE, and MALLS demonstrated that the fractions eluted from the solid phase contained well-defined components. Pegylated hemoglobin with one PEG chain was obtained with the yield of 75%, in comparison to the yield of 30% in the liquid phase pegylation. The P(50) values of the mono-pegylated hemoglobin, prepared with SC-mPEG 5 kDa, 10 kDa and 20 kDa, were 19.97, 20.23 and 20.54 mmHg, which were much closer to the value of red blood cells than that of pegylated hemoglobin prepared with the conventional method. A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange chromatography column and adsorbed by the solid medium. Succinimidyl carbonate mPEG was introduced in the mobile phase after the adsorption. Pegylation took place between the hemoglobin on the solid phase, and the pegylation reagent in the liquid phase. A further elution was carried out to separate the pegylated and the unpegylated protein. Analysis by HPSEC, SDS-PAGE, and MALLS demonstrated that the fractions eluted from the solid phase contained well-defined components. Pegylated hemoglobin with one PEG chain was obtained with the yield of 75%, in comparison to the yield of 30% in the liquid phase pegylation. The P 50 values of the mono-pegylated hemoglobin, prepared with SC-mPEG 5kDa, 10kDa and 20kDa, were 19.97, 20.23 and 20.54 mmHg, which were much closer to the value of red blood cells than that of pegylated hemoglobin prepared with the conventional method. A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange chromatography column and adsorbed by the solid medium. Succinimidyl carbonate mPEG was introduced in the mobile phase after the adsorption. Pegylation took place between the hemoglobin on the solid phase, and the pegylation reagent in the liquid phase. A further elution was carried out to separate the pegylated and the unpegylated protein. Analysis by HPSEC, SDS-PAGE, and MALLS demonstrated that the fractions eluted from the solid phase contained well-defined components. Pegylated hemoglobin with one PEG chain was obtained with the yield of 75%, in comparison to the yield of 30% in the liquid phase pegylation. The P50 values of the mono-pegylated hemoglobin, prepared with SC-mPEG 5kDa, 10kDa and 20kDa, were 19.97, 20.23 and 20.54 mmHg, which were much closer to the value of red blood cells than that of pegylated hemoglobin prepared with the conventional method. |
Author | Zheng, Chunyang Yu, Pengzhan Ma, Guanghui Su, Zhiguo Suo, Xiaoyan Lu, Xiuling |
Author_xml | – sequence: 1 givenname: Xiaoyan surname: Suo fullname: Suo, Xiaoyan email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China – sequence: 2 givenname: Chunyang surname: Zheng fullname: Zheng, Chunyang email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China – sequence: 3 givenname: Pengzhan surname: Yu fullname: Yu, Pengzhan email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China – sequence: 4 givenname: Xiuling surname: Lu fullname: Lu, Xiuling email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China – sequence: 5 givenname: Guanghui surname: Ma fullname: Ma, Guanghui email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China – sequence: 6 givenname: Zhiguo surname: Su fullname: Su, Zhiguo email: zgsu@home.ipe.ac.cn organization: 1National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People's Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19526439$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1LAzEQhoMo1qo_wIv0IN5WJx-bTdCLFL-gYEE9h2w6a1eym5pskf57V1oQEeppBuZ5X4ZnSHbb0CIhJxQuKCi4pFBwSjVo4CAoVWqHHNCcs0xQJXb7vb9nPaAHZJjSOwBwQdk-GVCdMym4PiBnz8HXs9F0bhOOpvi28rarQzsK1egBm_DmQ1m3R2Svsj7h8WYekte725fxQzZ5un8c30wyJ3jeZVZThxJBUusYOHBOFkpXzGFeFEVpJZVSKssZMDFjTmidO8chL1kJmKPih-R83buI4WOJqTNNnRx6b1sMy2RkIQqhBP8XZKC54kr3IF2DLoaUIlZmEevGxpWhYL4dmj8O-8zppnxZNjj7SWyk9cD1GqjbKsTGfoboZ6azKx9iFW3r6mT4tv6rX_E5Wt_NnY1o3sMytr3hLd99AXtAkGc |
CitedBy_id | crossref_primary_10_1016_j_chroma_2013_12_049 crossref_primary_10_1016_j_cocis_2017_09_003 crossref_primary_10_1016_j_procbio_2017_01_024 crossref_primary_10_1021_bm200541r crossref_primary_10_1155_2020_6163904 crossref_primary_10_1016_j_procbio_2011_10_016 crossref_primary_10_1016_j_jchromb_2015_08_027 crossref_primary_10_3109_10837450_2010_513990 crossref_primary_10_1002_cmdc_202000412 crossref_primary_10_1002_jmr_1095 |
Cites_doi | 10.1016/S0040-4039(02)00836-5 10.1081/BIO-120037828 10.1111/j.1470-8744.1992.tb00198.x 10.1016/S0021-9258(17)40291-2 10.1016/S0168-1656(02)00246-8 10.1021/bk-1997-0680 10.1021/bc050322y 10.1002/bit.21204 10.1053/beha.2000.0105 10.1038/nrd1033 10.1021/bc000021i 10.1016/S0969-2126(97)00181-0 10.1016/S0021-9258(18)90589-2 10.1038/227680a0 10.1073/pnas.94.16.8378 10.1021/bc060245m 10.1016/S0168-3659(01)00277-2 10.1016/j.ab.2006.04.020 |
ContentType | Journal Article |
Copyright | 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 |
Copyright_xml | – notice: 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 8FD FR3 P64 7X8 |
DOI | 10.1080/10731190903041188 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Engineering |
EISSN | 1532-4184 |
EndPage | 155 |
ExternalDocumentID | 10_1080_10731190903041188 19526439 404291 |
Genre | Original Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 00X 23N 36B 4.4 53G 5GY 5RE 5VS AALIY AALUX AAPXX ABBKH ABDBF ABPTK ABUPF ACGEJ ACGFS ADCVX ADFCX ADXPE AEYQI AFKVX AI. AIJEM AIRBT AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS ARJSQ AWYRJ B0M BABNJ BLEHA BRMBE CAG CCCUG COF CS3 CYYVM CZDIS DRXRE EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 KTTOD M44 M4Z ML0 OK1 P2P QQXMO QZIEQ SV3 TFL TFW TUS V1S VH1 ZXP ~8M ABJNI CGR CUY CVF ECM EIF NPM TDBHL AAYXX CITATION 7QO 8FD FR3 P64 7X8 |
ID | FETCH-LOGICAL-c435t-a91ce6e061ac20c0cc6789f2ce5777ba616668a32024d2c4995cc305b2b0e5e83 |
ISSN | 1073-1199 |
IngestDate | Fri Oct 25 04:49:22 EDT 2024 Sat Aug 17 04:01:25 EDT 2024 Fri Aug 23 00:47:43 EDT 2024 Sat Sep 28 07:55:00 EDT 2024 Tue Jun 13 19:22:49 EDT 2023 Wed Jun 21 13:15:14 EDT 2023 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c435t-a91ce6e061ac20c0cc6789f2ce5777ba616668a32024d2c4995cc305b2b0e5e83 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 19526439 |
PQID | 20938389 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | informahealthcare_journals_10_1080_10731190903041188 informaworld_taylorfrancis_310_1080_10731190903041188 proquest_miscellaneous_67474843 crossref_primary_10_1080_10731190903041188 proquest_miscellaneous_20938389 pubmed_primary_19526439 |
PublicationCentury | 2000 |
PublicationDate | 2009-01-01 |
PublicationDateYYYYMMDD | 2009-01-01 |
PublicationDate_xml | – month: 01 year: 2009 text: 2009-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Artificial cells, blood substitutes, and immobilization biotechnology |
PublicationTitleAlternate | Artif Cells Blood Substit Immobil Biotechnol |
PublicationYear | 2009 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
References | Gundersen S. (CIT0007) 2007; 96 CIT0020 Kroeger K.S. (CIT0014) 1997; 5 Chang T.M.S (CIT0004) 2000; 13 Gong X.W. (CIT0006) 2006; 354 Fronticelli C. (CIT0005) 1984; 259 Basu A. (CIT0002) 2006; 17 Harris J.M. (CIT0010) 2003; 2 Abuchowski A. (CIT0001) 1977; 252 Harris J.M. (CIT0009) 1997 Israelachvili J (CIT0012) 1997; 94 Lee B. K. (CIT0016) 2007; 18 Chang T.M.S (CIT0003) 1999; 17 Laemmli U.K (CIT0015) 1970; 227 Lu X.L. (CIT0017) 2004; 32 Zalipsky S. (CIT0021) 1992; 15 Hai T.T. (CIT0008) 2000; 11 Hu T. (CIT0011) 2003; 100 Planas M. (CIT0019) 2002; 43 Kozlowski A. (CIT0013) 2001; 72 Monkarsh S.P. (CIT0018) 1997 |
References_xml | – volume: 43 start-page: 4431 year: 2002 ident: CIT0019 publication-title: Tetrahedron Letters doi: 10.1016/S0040-4039(02)00836-5 contributor: fullname: Planas M. – volume: 32 start-page: 209 issue: 2 year: 2004 ident: CIT0017 publication-title: Artificial Cell, Blood Substitutes, and Biotechnology doi: 10.1081/BIO-120037828 contributor: fullname: Lu X.L. – volume: 15 start-page: 100 year: 1992 ident: CIT0021 publication-title: Biotechnol Appl Biochem doi: 10.1111/j.1470-8744.1992.tb00198.x contributor: fullname: Zalipsky S. – volume: 252 start-page: 3578 year: 1977 ident: CIT0001 publication-title: J. Biol. Chem doi: 10.1016/S0021-9258(17)40291-2 contributor: fullname: Abuchowski A. – volume: 100 start-page: 267 year: 2003 ident: CIT0011 publication-title: Journal of Biotechnology doi: 10.1016/S0168-1656(02)00246-8 contributor: fullname: Hu T. – start-page: 207 volume-title: Poly(ethyleneglycol) ACS Symposium Series year: 1997 ident: CIT0018 contributor: fullname: Monkarsh S.P. – ident: CIT0020 – volume-title: Poly (etylene glycol) Chemistry and Biological Applications year: 1997 ident: CIT0009 doi: 10.1021/bk-1997-0680 contributor: fullname: Harris J.M. – volume: 17 start-page: 618 year: 2006 ident: CIT0002 publication-title: Bioconjug Chem doi: 10.1021/bc050322y contributor: fullname: Basu A. – volume: 17 start-page: 181 issue: 2 year: 1999 ident: CIT0003 publication-title: Trends in Boitechnology. Tibtech contributor: fullname: Chang T.M.S – volume: 96 start-page: 1199 issue: 6 year: 2007 ident: CIT0007 publication-title: Biotechnology and Bioengineering doi: 10.1002/bit.21204 contributor: fullname: Gundersen S. – volume: 13 start-page: 651 year: 2000 ident: CIT0004 publication-title: Best Pract Res Clin Haematol doi: 10.1053/beha.2000.0105 contributor: fullname: Chang T.M.S – volume: 2 start-page: 214 year: 2003 ident: CIT0010 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1033 contributor: fullname: Harris J.M. – volume: 11 start-page: 705 year: 2000 ident: CIT0008 publication-title: Bioconjug Chem doi: 10.1021/bc000021i contributor: fullname: Hai T.T. – volume: 5 start-page: 227 issue: 2 year: 1997 ident: CIT0014 publication-title: Structure doi: 10.1016/S0969-2126(97)00181-0 contributor: fullname: Kroeger K.S. – volume: 259 start-page: 10841 year: 1984 ident: CIT0005 publication-title: J. Biol. Chem doi: 10.1016/S0021-9258(18)90589-2 contributor: fullname: Fronticelli C. – volume: 227 start-page: 680 issue: 259 year: 1970 ident: CIT0015 publication-title: Nature doi: 10.1038/227680a0 contributor: fullname: Laemmli U.K – volume: 94 start-page: 8378 year: 1997 ident: CIT0012 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.94.16.8378 contributor: fullname: Israelachvili J – volume: 18 start-page: 1728 year: 2007 ident: CIT0016 publication-title: Bioconjugate Chem doi: 10.1021/bc060245m contributor: fullname: Lee B. K. – volume: 72 start-page: 217 year: 2001 ident: CIT0013 publication-title: J. Control. Release doi: 10.1016/S0168-3659(01)00277-2 contributor: fullname: Kozlowski A. – volume: 354 start-page: 157 year: 2006 ident: CIT0006 publication-title: Anal Biochem doi: 10.1016/j.ab.2006.04.020 contributor: fullname: Gong X.W. |
SSID | ssj0003412 |
Score | 1.4937092 |
Snippet | A solid phase conjugation process was developed for attachment of polyethylene glycol to hemoglobin molecule. Bovine hemoglobin was loaded onto an ion exchange... |
SourceID | proquest crossref pubmed informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 147 |
SubjectTerms | Adsorption Animals Cattle Chromatography, High Pressure Liquid Chromatography, Ion Exchange Electrophoresis, Polyacrylamide Gel hemoglobin Hemoglobins - analysis Hemoglobins - chemistry Hemoglobins - isolation & purification Hemoglobins - metabolism Indicators and Reagents - chemistry Lasers Molecular Weight polyethylene glycol Polyethylene Glycols - chemistry red blood cell substitute Scattering, Radiation solid phase |
Title | Solid Phase Pegylation of Hemoglobin |
URI | https://www.tandfonline.com/doi/abs/10.1080/10731190903041188 https://www.ncbi.nlm.nih.gov/pubmed/19526439 https://search.proquest.com/docview/20938389 https://search.proquest.com/docview/67474843 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb5wwFLaqiVS1hyhNl0yTthxy6ogUG8PAMatGlVJFykQa9YJsY4aRUqgycEh-fZ8XloQmanNByAIDfs9v4_NnhPaDlEuIWoWbTWG6US8lLsMydCE09TJIuUjE1Grk8x_h7Ip-XwSLrqqkV5dU_EDc_XVdyXOkCm0gV7VK9j8k23YKDXAO8oUjSBiO_yTjy_J6lU4ucvBEkwu5vL1u47-Z_FUqrg_Lq93SzGpkkCqSq4K9FqFGrk_WYD8MaGDd4DlX8B0KOWvWaU74qqwGZfjLWldaFytW3nZq9jOXxoIc53UB7cvWtNQGElws7_IeFqg2fShM_PJeFSJ-UIWYDzYE6dlUsCIuxmYfpAPZ2FnQDGx2h2sMsWF_sQpHe1YVG1JO66Cx4fUd2H4DllRPg4ep8pNHIXuKOkfXwg-p8sKQMm8o9kQ6QhuHRydHZ60DB8duoarmvZuf4ZH3bdD7vXBmy5Ld5i107wEB7uNpjA5n5lto0-YhzqFRqjfohSy20eseO-U2enlucRdv0b7WNEdrmtNpmlNmTqdp79DV2en8eOba_TVcAUFy5bIYCxlKiOgUT6fwhIDIJc6IkMF0OuUsVL-UI-YTiONSIiA3DoQA_8AJ92QgI_89GhVlIXeQo1j7U0ZjwlJJccrikBOPQ1saCy5CMkZfm2FKfhsalQRbdtrBmI4RHQxkYqfd-qnbgv5YJ5XWycyoY-I_cd-XRigJ2FY1_1ghy3qdEC_2I4joH78ihGycRtQfow9Gmt3XxQFR0f7HZ77VLnrVzbM9NKpuavkJ4t-Kf7b6-gfIqah7 |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Solid+Phase+Pegylation+of+Hemoglobin&rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&rft.au=Suo%2C+Xiaoyan&rft.au=Zheng%2C+Chunyang&rft.au=Yu%2C+Pengzhan&rft.au=Lu%2C+Xiuling&rft.date=2009-01-01&rft.pub=Taylor+%26+Francis&rft.issn=1073-1199&rft.eissn=1532-4184&rft.volume=37&rft.issue=4&rft.spage=147&rft.epage=155&rft_id=info:doi/10.1080%2F10731190903041188&rft.externalDocID=404291 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-1199&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-1199&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-1199&client=summon |